| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/10/1997 | CA2213232A1 Parenteral pharmaceutical compositions containing ammoniumalkyl salts of 2-arylpropionic acids |
| 07/09/1997 | EP0783038A1 Recombinant viral pseudoparticles and their applications as vaccines or as antitumour agents |
| 07/09/1997 | EP0783002A2 Dual action inhibitors |
| 07/09/1997 | EP0783001A1 Androstenones |
| 07/09/1997 | EP0782986A1 Novel heterocyclic derivatives, process for producing the same, and medicinal use thereof |
| 07/09/1997 | EP0782984A2 Process of preparing 2-2'-(1-Methyl-1,2-Ethanediylidene) bis (Hydrazine carboximidamide) |
| 07/09/1997 | EP0782983A2 Process of preparing 2,2'-(1-Methyl-1,2-Ethanediylidene) bis (Hydrazine carboximidamide) |
| 07/09/1997 | EP0782857A1 Remedy and preventive for nervous system disorder |
| 07/09/1997 | EP0782856A1 Carbostyril derivatives for reducing infarct size in subjects afflicted with ischemic heart disease |
| 07/09/1997 | EP0782855A1 Antiinflammatory agent for external use |
| 07/09/1997 | EP0782854A2 Use of isopropyl-2-(1,3-dithietan-2-ylidene)-2-(N-(4-methylthiazol-2-yl)carbamoyl)acetate as a cancer chemopreventive agent |
| 07/09/1997 | EP0782852A1 Pharmaceutical compositions of heterocyclic angiotensin-II antagonists for oral use and method of preparing them |
| 07/09/1997 | EP0782632A1 A method for identifying and using compounds that inactivate hiv-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
| 07/09/1997 | EP0782631A1 Treatment of plasmodium |
| 07/09/1997 | EP0782630A1 Polycystic kidney disease gene |
| 07/09/1997 | EP0782622A1 RIBOZYME TREATMENT OF DISEASES OR CONDITIONS RELATED TO LEVELS OF PLASMA LIPOPROTEIN (a) Lp(a)] BY INHIBITING APOLIPOPROTEIN (a) APO(a)] |
| 07/09/1997 | EP0782615A1 Dna encoding human papillomavirus type 6a |
| 07/09/1997 | EP0782582A1 EPIMERS OF (22RS)-N-(1,1,1-TRIFLUORO-2-PHENYLPROP-2-YL)-3-OXO-4-AZA-5$g(a)-ANDROST-1-ENE-17$g(b)-CARBOXAMIDE |
| 07/09/1997 | EP0782580A1 Parallel selex |
| 07/09/1997 | EP0782579A1 Dna photocleavage using texaphyrins |
| 07/09/1997 | EP0782574A1 Bicyclic carboxamides as 5-ht 1a? antagonists |
| 07/09/1997 | EP0782573A1 Drugs to improved synaptic transmission |
| 07/09/1997 | EP0782571A1 Compositions and methods for treating mast-cell inflammatory condition |
| 07/09/1997 | EP0782570A1 Substituted heteroaromatic compounds and their use in medicine |
| 07/09/1997 | EP0782568A1 Aromatic ethers derived from indols such as 5ht1-like ligands |
| 07/09/1997 | EP0782567A1 Isothiourea derivatives as no synthase inhibitors |
| 07/09/1997 | EP0782455A1 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 07/09/1997 | EP0782454A1 Use of muramyl peptide compounds |
| 07/09/1997 | EP0782451A1 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
| 07/09/1997 | EP0782450A1 Use of aromatase inhibitors in the preparation of a drug for treating a relative androgen deficiency in men |
| 07/09/1997 | EP0782449A1 Process of making dosage units by wet granulation |
| 07/09/1997 | EP0782448A1 Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
| 07/09/1997 | EP0782447A1 Method and means for prevention and treatment of secondary cataract |
| 07/09/1997 | EP0782446A1 Methods of inhibiting endometrial mitoses |
| 07/09/1997 | EP0782445A1 Combination of an opioid antagonist and a selective serotonin reuptake inhibitor for treatment of alcoholism and alcohol dependence |
| 07/09/1997 | EP0782444A1 Method of inhibiting conditions associated with bradykinin |
| 07/09/1997 | EP0782443A1 Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt |
| 07/09/1997 | EP0782442A1 A delivery system for antimethanogenic agents |
| 07/09/1997 | EP0782441A1 Pharmaceutical control of inflammation |
| 07/09/1997 | EP0720608B1 Novel dihispidine derivatives, process for producing them and medicaments containing these compounds |
| 07/09/1997 | EP0720602B1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents |
| 07/09/1997 | EP0681580B1 Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| 07/09/1997 | EP0677046B1 Piperazine derivatives as 5-ht antagonists |
| 07/09/1997 | EP0663836B1 Treatment of autoimmune and inflammatory disorders |
| 07/09/1997 | EP0478775B1 Peptide derivatives |
| 07/09/1997 | EP0464084B1 Use of eicosapentaenoic acid for the treatment of cachexia |
| 07/09/1997 | CN1154123A Antiviral dendrimers |
| 07/09/1997 | CN1154114A New thrombin inhibitors, their preparation and use |
| 07/09/1997 | CN1154113A Tetracyclic triterpenes |
| 07/09/1997 | CN1154112A Dinucleoside-5',5'-pyrophosphates |
| 07/09/1997 | CN1154111A New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 07/09/1997 | CN1154110A Compounds useful as antiproliferative agents and GARFT inhibitors |
| 07/09/1997 | CN1154109A Semi-synthetic taxanes with anti-tumoural activity |
| 07/09/1997 | CN1154107A Serotonin 5-HT1A and dopamin D2 receptor ligands |
| 07/09/1997 | CN1154106A Aromatic amino ethers as pain relieving agents |
| 07/09/1997 | CN1154067A Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 07/09/1997 | CN1154066A Preparation of fusidic acid tablets |
| 07/09/1997 | CN1154065A Carbon monoxide dependent guanylyl cyclase modifiers |
| 07/09/1997 | CN1154064A Therapeutic agent for liver regeneration |
| 07/09/1997 | CN1153784A Biotin derivatives |
| 07/09/1997 | CN1153778A Rosemary acid dimer compound and its separation process |
| 07/09/1997 | CN1153773A substituted benzoyl guanidine its preparation, application as medicine or diagnostic reagent and medicine containing the said compound |
| 07/09/1997 | CN1153666A Wumai'an slow releasing prepn |
| 07/09/1997 | CN1153634A Medicine for prevention and treatment of calcium deficiency and its prepn |
| 07/09/1997 | CN1153633A Contraceptive killing sperm in vagina and its prepn |
| 07/09/1997 | CN1035380C Preparation method for trifluoromethane-sulfonyl derivative of 10-hydroxy-camptothecine |
| 07/09/1997 | CN1035357C Preparation for medicinal liquid composition containing triazoles compound and a solvent system |
| 07/09/1997 | CN1035356C Method for preparing antiparasitic formulations |
| 07/09/1997 | CN1035355C Preparation for coating agent of complex triamcinolone acetonide acetate |
| 07/09/1997 | CA2188374A1 Benzene-condensed heterocyclic derivatives and their use |
| 07/09/1997 | CA2166758A1 Condom and genital lubricants containing zinc salts which inhibit hiv viruses |
| 07/08/1997 | US5646321 Guerbet meadowfoam esters |
| 07/08/1997 | US5646313 Preparing enkephalinase inhibitors |
| 07/08/1997 | US5646309 Serotonin receptor antagonists; central nervous system disorders |
| 07/08/1997 | US5646308 Benzopyran derivatives |
| 07/08/1997 | US5646303 Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein |
| 07/08/1997 | US5646300 Neuroprotective agents |
| 07/08/1997 | US5646294 Orally active azole derivatives |
| 07/08/1997 | US5646289 Reacting a 3-chloro-1,2,5-thiadiazole with alkali metal bis(trialkyl or arylsilyl)amide; dechlorination; treating nervous system disorders |
| 07/08/1997 | US5646272 Bile acid conjugates of proline hydroxylase inhibitors |
| 07/08/1997 | US5646268 Process producing lower molecular weight range oligodeoxyribonucleotides |
| 07/08/1997 | US5646262 Binds encapsidation sequence of messenger rna intermediate; genetic engineering |
| 07/08/1997 | US5646261 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use |
| 07/08/1997 | US5646190 Acne treating-wound healing compositions and methods for preparing and using same |
| 07/08/1997 | US5646189 Prevention of HIV infection |
| 07/08/1997 | US5646188 Polyamine derivatives of 1-aminoindan |
| 07/08/1997 | US5646187 For treating patients suffering from organ failure or sepsis and a general protein catabolism |
| 07/08/1997 | US5646186 Glycolic acid antiirritant |
| 07/08/1997 | US5646185 Administering protein kinase c activator consisting of phorbol ester, diacylglycerol, or thapsigargin to hypoxic cells |
| 07/08/1997 | US5646182 Administering a mixture of a phenylacetylglutamine compound and a phenylacetic acid compound to a patient |
| 07/08/1997 | US5646181 Method and compositions for treating impotence |
| 07/08/1997 | US5646180 Treatment of the CNS effects of HIV |
| 07/08/1997 | US5646178 Interfering with non-viral microbial tissue adhesion to body tissue |
| 07/08/1997 | US5646175 Carbamoyloxylabdane compounds |
| 07/08/1997 | US5646174 Preventing bone loss after surgery |
| 07/08/1997 | US5646173 Tricyclic pyrrole derivatives useful as 5-HT selective agents |
| 07/08/1997 | US5646172 Method of inducing antiandrogenic activity using imidazolidines substituted with a heterocycle |
| 07/08/1997 | US5646170 Tetrazole alkyl amide acat inhibitors |
| 07/08/1997 | US5646169 Administering substituted thiazolidinedione derivatives to humans or other mammals |
| 07/08/1997 | US5646168 Hypoglycemic hydroxyurea derivatives |